Trial
NCT03867188
Liposomal Bupivacaine (Exparel) in Sarcomas
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Soft Tissue Sarcoma
Intervention
Liposomal Bupivacaine
Why stopped
Enrollment of eligible subjects, delays due to the COVID-19 Virus, and lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-22